$3.80-0.15|(-3.80%)
52W H: 6.5152W L: 2.23Beta: 1.09

About MannKind Corp

Frequently Asked Questions

What is the 52-week range for MNKD?

The 52-week high is $6.51 and the 52-week low is $2.23.

What is the P/E ratio for MNKD?

The P/E ratio data is currently unavailable.

What is the dividend yield for MNKD?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -297.71%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -10.87%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 4.03.

Analyst Recommendation Trends

Wall Street analyst consensus for MNKD over the last few months:

2026-09-01
Buy: 8
S.Buy: 4
Hold: 2
Sell: 0
2026-08-01
Buy: 8
S.Buy: 4
Hold: 2
Sell: 0
2026-07-01
Buy: 8
S.Buy: 4
Hold: 2
Sell: 0
2026-06-01
Buy: 8
S.Buy: 4
Hold: 2
Sell: 0

Latest MNKD News

United Therapeutics: The Market Sees The Erosion, Not The Refill - Buy

United Therapeutics' declines are real but they sit in ~32% of the business, tax-normalized earnings power is $1.05 billion. See why UTHR stock is a Buy now.

SeekingAlpha9/27/2026

MannKind Sees Early ReadyFlow Demand as Pediatric Afrezza Launch Gains Momentum

MannKind (NASDAQ:MNKD) CFO Chris Prentiss outlined the company’s commercial and development priorities at the H.C. Wainwright Global Investment Conference, emphasizing execution following three major 2026 catalysts: expanded pediatric approval for Afrezza, the launch of FUROSCIX ReadyFlow, and Phase

Yahoo9/17/2026

MannKind (MNKD) Bets On Inhaled Weight Loss Amid Widening Losses

On September 9, MannKind Corporation (NASDAQ:MNKD) announced a licensing and collaboration agreement with Rose Pharma Inc. to develop ROSE-010 Technosphere, an inhaled, rapid-acting glucagon-like peptide-1 receptor agonist aimed at weight management. The deal hands MannKind an equity stake in Rose Pharma, a board seat, and royalty rights on future sales, without saddling it with the […]

Yahoo9/16/2026

Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target

Cantor Fitzgerald analyst Olivia Brayer Saunders reiterates MannKind (NASDAQ:MNKD) with a Overweight and maintains $8 price target.

Benzinga9/11/2026

MannKind Expands Into Weight Loss With Rose Pharma Deal – Here’s What Investors Are Watching

MannKind and Rose Pharma are partnering to develop an inhaled weight-loss treatment using the Technosphere dry-powder inhalation technology.

Yahoo9/9/2026

Breathing In GLP-1: MannKind Partners With Rose Pharma for Inhaled Weight Management Molecule

MannKind licenses Technosphere GLP-1 tech to Rose Pharma for weight management development.

Benzinga9/9/2026

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management

Collaboration combines Rose Pharma investigational rapid-acting GLP-1 receptor agonist with MannKind’s Technosphere® inhalation technologyMannKind to receive an equity interest and potential royalties while providing pharmaceutical development and manufacturing support through completion of a Phase 1b clinical study DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company focused on developing innovative, pat

Yahoo9/9/2026

MannKind And Rose Pharma Enter Into Worldwide Licensing And Collaboration Agreement To Develop ROSE-010 Technosphere For Weight Management

Collaboration combines Rose Pharma investigational rapid-acting GLP-1 receptor agonist with MannKind’s Technosphere® inhalation technologyMannKind to receive an equity interest and potential royalties while providing

Benzinga9/9/2026

Related Stocks (Peers)

Companies operating in similar sectors to MNKD:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-25Binder Steven B.-39,051$3.29$128,478
2026-09-10Binder Steven B.-33,558$3.81$127,856
2026-08-07Binder Steven B.-39,051$4.06$158,547
2026-07-17Binder Steven B.-52,485$4.06$213,089
2026-07-17Thomson David-24,109$4.05$97,641
2026-07-15Marasco Dominic-3,623$4.09$14,818
2026-07-15Singh Sanjay R-70,550--
2026-07-15Singh Sanjay R-9,297$4.09$38,025
2026-07-15Singh Sanjay R-10,079$4.09$41,223
2026-07-15Singh Sanjay R-5,372$4.09$21,971
2026-07-15Singh Sanjay R-22,047$4.09$90,172
2026-07-15Singh Sanjay R+70,550--
2026-07-15Prentiss Christopher B-10,675$4.09$43,661
2026-07-15Prentiss Christopher B-11,572$4.09$47,329
2026-07-15Binder Steven B.-93,790--
2026-07-15Binder Steven B.-4,634$4.09$18,953
2026-07-15Binder Steven B.-4,073$4.09$16,659
2026-07-15Binder Steven B.-15,688$4.09$64,164
2026-07-15Binder Steven B.+93,790--
2026-07-15Castagna Michael-350,260--
2026-07-15Castagna Michael-58,904$4.09$240,917
2026-07-15Castagna Michael-63,996$4.09$261,744
2026-07-15Castagna Michael-47,481$4.09$194,197
2026-07-15Castagna Michael-192,819$4.09$788,630
2026-07-15Castagna Michael+350,260--
2026-07-15Tross Stuart A-93,790--
2026-07-15Tross Stuart A-12,331$4.09$50,434
2026-07-15Tross Stuart A-11,572$4.09$47,329
2026-07-15Tross Stuart A-8,253$4.09$33,755
2026-07-15Tross Stuart A-33,652$4.09$137,637
2026-07-15Tross Stuart A+93,790--
2026-07-15Thomson David-93,790--
2026-07-15Thomson David-16,378$4.09$66,986
2026-07-15Thomson David-17,754$4.09$72,614
2026-07-15Thomson David-12,662$4.09$51,788
2026-07-15Thomson David-51,632$4.09$211,175
2026-07-15Thomson David+93,790--
2026-05-20Marasco Dominic+8,474$2.95$24,998
2026-05-20Kay Sabrina+82,781--
2026-05-20Grancio Jennifer+82,781--
2026-05-20Binder Steven B.+82,781--
2026-05-20Tross Stuart A+33,898$2.95$99,999
2026-05-20Shannon James Samuel+16,556--
2026-05-20Shannon James Samuel+82,781--
2026-05-20Friedman Michael A+82,781--
2026-05-20HOOPER ANTHONY C+16,556--
2026-05-20HOOPER ANTHONY C+82,781--
2026-05-20MUNDKUR CHRISTINE+82,781--
2026-05-20Consiglio Ronald J+16,556--
2026-05-20Consiglio Ronald J+82,781--
2026-05-20Consiglio Ronald J+10,000$2.95$29,500
2026-05-12Binder Steven B.-16,940$3.29$55,733
2026-05-12Thomson David-3,033$3.29$9,979
2026-05-11Binder Steven B.-5,560$3.52$19,571
2026-05-11Castagna Michael-34,957$3.52$123,049
2026-05-11Tross Stuart A-8,073$3.52$28,417
2026-05-11Thomson David-12,387$3.52$43,602
2026-04-22Prentiss Christopher B-12,267$2.74$33,612
2026-03-23Ahuja Ajay+217,000--
2026-03-23Ahuja Ajay+221,000--
2026-03-23Singh Sanjay R+217,000--
2026-03-23Singh Sanjay R+221,000--
2026-03-23Prentiss Christopher B+217,000--
2026-03-23Prentiss Christopher B+221,000--
2026-03-23Castagna Michael+782,000--
2026-03-23Castagna Michael+796,000--
2026-03-23Tross Stuart A+217,000--
2026-03-23Tross Stuart A+221,000--
2026-03-23Thomson David+217,000--
2026-03-23Thomson David+221,000--
2026-03-10Castagna Michael+100,000$2.59$259,000
2026-03-01Prentiss Christopher B+5,000$3.27$16,350
2026-03-01Shannon James Samuel+12,000$3.27$39,240
2026-03-01HOOPER ANTHONY C+35,000$3.27$114,450
2026-03-01Castagna Michael+15,290$3.27$49,998
2026-03-01Tross Stuart A+15,290$3.27$49,998
2026-02-26Binder Steven B.+45,025--
2026-02-26Castagna Michael+37,525--
2026-02-26Castagna Michael+57,750--
2026-02-26Castagna Michael+50,000--
2026-02-26Tross Stuart A+28,143--
2026-02-26Tross Stuart A+20,000--
2026-02-26Thomson David+37,525--
2026-02-26Thomson David+20,000--
2026-01-08Tross Stuart A-47,006$6.33$297,548
2025-12-24Castagna Michael-44,171--
2025-12-17Castagna Michael-50,000--
2025-12-17Castagna Michael-15,804--
2025-12-17Castagna Michael-65,804$6.01$395,482
2025-12-17Castagna Michael+65,804$4.55$299,408
2025-12-16Castagna Michael-21,310--
2025-12-16Castagna Michael-21,310$6$127,860
2025-12-16Castagna Michael+21,310$4.55$96,961
2025-12-12Castagna Michael-12,886--
2025-12-12Castagna Michael-7,920--
2025-12-12Castagna Michael-20,806$6$124,836
2025-12-12Castagna Michael+20,806$4.55$94,667
2025-12-02Castagna Michael-42,080--
2025-12-02Castagna Michael-65,840--
2025-12-02Castagna Michael-107,920$5.57$601,114
2025-12-02Castagna Michael+107,920$4.55$491,036
2025-12-02Thomson David-87,780--
2025-12-02Thomson David-20,000--
2025-12-02Thomson David-20,000--
2025-12-02Thomson David-20,000--
2025-12-02Thomson David-147,780$5.57$823,135
2025-12-02Thomson David+87,780$4.6$403,788
2025-12-02Thomson David+60,000$4.55$273,000
2025-11-14Singh Sanjay R-18,777$5.03$94,448
2025-11-11Ahuja Ajay+318,200--
2025-10-31Singh Sanjay R-17,071$5.59$95,427